摘要
目的探讨尿激酶溶栓对急性脑梗死的疗效。方法选择经CT扫描确诊的30例急性脑梗死病例，同时选择32例具有可比性的病例作为对照组。治疗组用50万U尿激酶用10mL生理盐水溶解后静注，然后用100万U的尿激酶加入到100mL生理盐水中内于30min内滴入，溶栓前口服阿斯匹林0．3g／d，连用3d后改为75mg／d，溶栓后12h用肝素12500u／d静点。连用7～10d。对照组用脱水荆和活血化瘀药物治疗，用药前后两组分别检测相关指标。结果治疗组肌力提高3级16例，提高2级4例，提高1级9例，无变化1例。对照组提高1级6例，肌力下降1级14例，无变化12例。结论早期应用尿激酶溶栓治疗急性脑梗死疗效突出、安全。
Objective To discuss the curative effect of thombolysis of urokinase for acute cerebral infarction（ACI）. Methods 30 cases of ACI patient obtained diagnosis on CT were compared with 32 cases with comparability as control were analyzed. The therapy group was treated with 0.5 miUion u with 10 mL of saline injection first and 1 million u with 100 mL saline injection of urokinase. The asprin and heparin were also used in therapy group. The control group was treated with dehydrate and promote blood and dissolve hemostasis. The lab was detected and compared. Results There were 16 cases of muscle strength improved 3 degree, 4 cases of MS improved 4 degree, 9 cases of MS improved 1 degree and 1 case of MS no change in therapy group. There were 6 cases of muscle strength improved 1 degree, 14 cases of MS decreased, and 12 case of MS no change in control group. Conclusion The curative effect of early use of urokinase to treat ACI might be remarkable and safe.
出处
《黑龙江医学》
2006年第1期40-41,共2页
Heilongjiang Medical Journal
关键词
神经病学
尿激酶
急性脑梗死
Neurology
Urokinase thrombolysis
Acute cerebral infarction
